Intravenous tolerization with type II collagen induces interleukin‐4‐and interleukin‐10‐producing CD4 + T cells-Reference-Cited by-同舟云学术

Intravenous tolerization with type II collagen induces interleukin‐4‐and interleukin‐10‐producing CD4 + T cells

Published:1999-07 Issue:3 Volume:97 Page:466-473
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Gumanovskaya ¹²,Myers ³,Rosloniec ¹²,Stuart ¹²,Kang ¹²

Affiliation:

1. Departments of Internal Medicine

2. The Research Service of the Veterans Administration Medical Center, Memphis, TN, USA

3. Pediatrics, University of Tennessee, Memphis, TN

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2567.1999.00778.x

Reference39 articles.

1. Collagen‐induced arthritis in rats: antigen specific suppression of arthritis and immunity by intravenously injected native type II collagen.;Cremer M.A.;J Immunol,1983

2. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen.

3. Gastric administration of type II collagen delays the onset and severity of collagen‐induced arthritis in rats.;Thompson H.S.;Clin Exp Immunol,1986

4. Passive transfer of arthritis in mice by human anti‐type II collagen antibody.;Wooley P.H.;Mayo Clinic Proc,1984

5. Suppression of murine collagen‐induced arthritis by nasal administration of collagen

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Administration of Proteoglycan Protects BALB/c Retired Breeder Mice from Experimental Arthritis;Journal of Immunology Research;2016

2. Functional Mechanism(s) of the Inhibition of Disease Progression by Combination Treatment with Fingolimod Plus Pathogenic Antigen in a Glucose-6-phosphate Isomerase Peptide-Induced Arthritis Mouse Model;Biological & Pharmaceutical Bulletin;2015

3. Mechanism of induction of immune tolerance in experimental autoimmune encephalomyelitis by combination treatment with fingolimod plus pathogenic autoantigen;Clinical and Experimental Neuroimmunology;2014-08-22

4. Red blood cells as innovative antigen carrier to induce specific immune tolerance;International Journal of Pharmaceutics;2013-02

5. Efficacy of Combination Treatment with Fingolimod (FTY720) Plus Pathogenic Autoantigen in a Glucose-6-phosphate Isomerase Peptide (GPI_325–339)-Induced Arthritis Mouse Model;Biological and Pharmaceutical Bulletin;2013